Unknown

Dataset Information

Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.


ABSTRACT: Clonal heterogeneity is a hallmark of malignant transformation. In acute myeloid leukemia, acquired cytogenetic abnormalities are important independent predictors of initial response to therapy, remission duration, and overall survival. However, whether the presence of multiple cytogenetically characterized clones affects outcomes in acute myeloid leukemia is still not well defined. The aim of this study was to assess the prognostic impact of cytogenetic clonal heterogeneity in acute myeloid leukemia. This analysis included 1403 newly diagnosed acute myeloid leukemia patients fit for intensive chemotherapy, aged between 15 and 88 years, enrolled on Southwest Oncology Group protocols. The presence of multiple cytogenetic clones was found in 164 (24%) patients with abnormal karyotype. The pr

SUBMITTER: Medeiros BC 

PROVIDER: S-EPMC4349271 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature